drugset

drugset / Trial / NCT01349010

Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

NCT01349010 ↗

Phase 3 Completed 264 enrolled Otsuka Beijing Research Institute

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of imported Probucol in hyperlipidemia patients.

Timeline

Start: 2011-04
Primary completion: 2012-07
Completion: 2013-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Probucol	Small molecule	250 mg	Oral

Indications